Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes por Walter Suárez Carmona | Jun 23, 2025
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes por Walter Suárez Carmona | Jun 23, 2025
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo- controlled, phase 3 trial por Walter Suárez Carmona | Jun 23, 2025
